Cite
Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.
MLA
Jiang, Wenbin, et al. “Immune Inactivation by CD47 Expression Predicts Clinical Outcomes and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients.” Urologic Oncology, vol. 40, no. 4, Apr. 2022, p. 166.e15-166.e25. EBSCOhost, https://doi.org/10.1016/j.urolonc.2021.11.024.
APA
Jiang, W., Zeng, H., Liu, Z., Jin, K., Hu, B., Chang, Y., Liu, L., Zhu, Y., Xu, L., Wang, Z., Guo, J., & Xu, J. (2022). Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients. Urologic Oncology, 40(4), 166.e15-166.e25. https://doi.org/10.1016/j.urolonc.2021.11.024
Chicago
Jiang, Wenbin, Han Zeng, Zhaopei Liu, Kaifeng Jin, Baoying Hu, Yuan Chang, Li Liu, et al. 2022. “Immune Inactivation by CD47 Expression Predicts Clinical Outcomes and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients.” Urologic Oncology 40 (4): 166.e15-166.e25. doi:10.1016/j.urolonc.2021.11.024.